Group 1 - The company is holding its second extraordinary general meeting of shareholders in 2025 to ensure the rights of all shareholders and maintain order during the meeting [1] - Only shareholders, their proxies, company directors, supervisors, senior management, invited lawyers, and designated personnel are allowed to attend the meeting [1][2] - Shareholders and their proxies must register at least half an hour before the meeting and present required documentation [1][2] Group 2 - The meeting will announce the number of attending shareholders and their voting rights before allowing any latecomers to participate [2] - Shareholders have the right to speak, inquire, and vote, but must adhere to the meeting's agenda and time limits for speaking [2][3] - The meeting will utilize both on-site and online voting methods, with results to be announced in a company resolution [3][4] Group 3 - The agenda includes a proposal to lower the conversion price of the "Shan Stone Convertible Bond" due to specific market conditions [4][5] - The proposal is based on the condition that the stock price has been below 85% of the conversion price for at least 15 out of 30 trading days [4][5] - The board of directors seeks authorization to handle the necessary adjustments related to the bond conversion price [5]

Core Viewpoint - The company has announced the potential for a downward adjustment of the conversion price for its convertible bonds, "Aoweizhuan," due to the stock price falling below 85% of the current conversion price [1][10]. Summary by Sections Convertible Bond Basic Information - The company issued 11.4 million convertible bonds at a total value of 1.14 billion yuan, with a face value of 100 yuan each, on August 10, 2023 [1]. - The conversion price is set at 84.88 yuan per share, with the conversion period from February 19, 2024, to August 9, 2029 [1]. Conversion Price Adjustment History - The conversion price was adjusted from 180.74 yuan to 124.65 yuan on November 17, 2023, following a capital increase plan [1]. - Subsequent adjustments occurred, with the conversion price changing to 124.62 yuan on January 9, 2024, and further adjustments leading to 87.56 yuan on May 20, 2024 [3][4]. - The latest adjustment set the conversion price at 86.60 yuan on November 25, 2024, and further reduced it to 86.58 yuan on January 9, 2025 [5][6]. Potential Trigger for Downward Adjustment - The company indicated that if the stock price remains below 72.15 yuan (85% of the conversion price) for 15 out of 30 trading days, it may trigger a downward adjustment of the conversion price [10]. - As of June 18, 2025, the stock price had been below this threshold for ten trading days, indicating a potential for further adjustment [10]. Profit Distribution Plans - The company plans to distribute cash dividends of 8.60 yuan per 10 shares, totaling approximately 270.41 million yuan, as approved on September 6, 2024 [4]. - The conversion price was adjusted to 86.70 yuan following this distribution, effective from October 15, 2024 [4]. Recent Developments - The company completed the registration of shares for its incentive plans, leading to further adjustments in the conversion price, with the latest being 84.88 yuan effective from June 10, 2025 [9].

Group 1 - The company held its fourth board meeting on June 18, 2025, with all nine directors present, including five participating via remote voting [1] - The board approved a proposal to lower the conversion price of the "Jialitu Convertible Bonds" to 85% of the current stock price, which is 9.10 CNY per share, and 9.04 CNY per share for the period from June 9 to June 18, 2025 [1][2] - The adjustment is triggered as the stock price has been below the conversion price for 15 consecutive trading days [1] Group 2 - The board proposed to authorize the shareholders' meeting to allow the board to handle the necessary procedures for the price adjustment, including determining the new conversion price and effective date [2] - The proposal to adjust the conversion price requires approval from at least two-thirds of the voting rights at the shareholders' meeting, with bondholders required to abstain from voting [3] - The company plans to hold the fourth extraordinary shareholders' meeting on July 10, 2025, to discuss the proposals [4]

Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds despite triggering conditions for a downward adjustment, aiming to maintain investor confidence and protect their interests [1][2]. Group 1: Meeting Details - The fifth board meeting of the company was held on June 11, 2025, with all five directors present, including two independent directors [1]. - The meeting was conducted in compliance with relevant laws and regulations, ensuring its legality and validity [1]. Group 2: Bond Conversion Price Decision - The board unanimously approved the proposal not to adjust the conversion price of the "Zhongzhuang Zhuan 2" bonds, despite the stock price being below 85% of the conversion price for at least 15 trading days [1]. - The current conversion price is set at 4.08 yuan per share, and the decision was made after considering the company's fundamental situation and stock price trends [1]. - The board indicated that if the conditions for adjustment are triggered again, they will convene another meeting to decide on the matter [1].

Group 1 - The company has decided to lower the conversion price of its convertible bonds due to the stock price being below 85% of the current conversion price for at least 15 trading days within a 30-day period [1][2] - The new conversion price is set at RMB 4.80 per share, which complies with the requirements of being higher than the average trading price of the stock over the previous 20 trading days and the latest audited net asset value per share [2] - The adjustment to the conversion price will take effect on May 21, 2025, following the approval from the board and the shareholders' meeting [2][3] Group 2 - The company issued 11.6 million convertible bonds with a total value of RMB 116 million, which were approved by the China Securities Regulatory Commission [1] - The bondholders must abstain from voting during the shareholders' meeting regarding the adjustment of the conversion price [2] - The board's decision aims to protect the interests of bondholders and optimize the company's capital structure for long-term development [1][2]

Core Viewpoint - The company, Hainan Puli Pharmaceutical Co., Ltd., has announced that its convertible bonds will enter a delisting arrangement starting from April 28, 2025, with the last trading date expected to be May 21, 2025 [1] Group 1: Convertible Bond Details - The company issued 8.5 million convertible bonds with a face value of RMB 100 each, raising a total of RMB 850 million, with a net amount of RMB 837.86 million after deducting fees [2][3] - The convertible bonds were listed on the Shenzhen Stock Exchange on March 8, 2021, under the name "Puli Convertible Bonds" with the code "123099" [3] - The bond's conversion period began six months after the issuance date and will last until the maturity date of the bonds [4] Group 2: Conversion Price Adjustments - The conversion price of the bonds has been adjusted multiple times, with the latest adjustment setting it at RMB 19.76 per share effective from July 18, 2023 [8][9] - The board proposed to further lower the conversion price to RMB 11.22 per share effective from November 20, 2024, and subsequently to RMB 4.89 per share effective from January 23, 2025 [10][11] - The company has the authority to propose adjustments to the conversion price if the stock price falls below 85% of the current conversion price for a specified period [12][13]

证券代码：002822 证券简称：ST中装 公告编号：2025-058 债券代码：127033 债券简称：中装转2 深圳市中装建设集团股份有限公司 "中装转2"2025年 第一次债券持有人会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或者重大遗漏。 根据《深圳市中装建设集团股份有限公司公开发行可转换公司债券募集说明书》（以下简称"《可转债 募集说明书》"）《深圳市中装建设集团股份有限公司可转换公司债券持有人会议规则》的相关规定， 深圳市中装建设集团股份有限公司（以下简称"公司"）董事会召集的"中装转2"2025年第一次债券持有 人会议（以下简称"本次会议"）于2025年4月25日召开。现将本次会议召开情况公告如下： 一、会议召开的基本情况 1、会议届次："中装转2"2025年第一次债券持有人会议 2、会议召集人：公司第五届董事会。 3、会议主持人：董事兼副总裁赵海峰先生 4、会议召开的合法、合规性：本次债券持有人会议的召集、召开程序符合有关法律、行政法规、部门 规章、规范性文件和《公司章程》《债券持有人会议规则》等相关规定。 5、会议召开的时间：2025年4月25日 ...

证券代码：688026 证券简称：洁特生物 公告编号：2025-010 转债代码：118010 转债简称：洁特转债 广州洁特生物过滤股份有限公司 第四届董事会第十七次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 广州洁特生物过滤股份有限公司（以下简称"公司"）第四届董事会第十七次会议于2025年4月11日以现 场及通讯相结合方式召开，会议通知已于2025年4月3日通过通讯方式送达全体董事。本次会议由董事长 袁建华先生召集并主持，应参加董事7人，实际参加表决董事7人。本次会议的召集、召开和表决程序均 符合国家有关法律、法规及《公司章程》等有关规定。经全体董事一致同意，形成决议如下： 一、以4票同意，0票反对，0票弃权，审议通过了《关于不向下修正"洁特转债"转股价格的议案》，关 联董事袁建华、Yuan Ye James、Dannie Yuan回避表决。 董事会同意本次不向下修正转股价格，同时在未来三个月内（即日起至2025年7月11日）如再次触发可 转换公司债券转股价格向下修正条款的，亦不提出向下修正方案。在此期 ...

Core Viewpoint - Ningbo Meinuo Pharmaceutical Co., Ltd. has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock prices falling below 90% of the current conversion price for a significant number of trading days [2][8]. Group 1: Convertible Bond Overview - The company issued 520 million yuan worth of convertible bonds on January 14, 2021, with a maturity of six years and an initial conversion price of 37.47 yuan per share [3]. - The bond trading began on February 4, 2021, under the name "Meinuo Convertible Bonds" with the code "113618" [3]. Group 2: Conversion Price Adjustment History - The conversion price has been adjusted multiple times since issuance, including a reduction to 26.51 yuan per share after a rights issue in June 2022 and further adjustments leading to the current price of 25.84 yuan per share [4][5]. - The most recent adjustment occurred on July 12, 2024, when the price was set at 25.84 yuan per share following a rights distribution [5]. Group 3: Downward Adjustment Clause - The downward adjustment clause is triggered when the stock price falls below 90% of the conversion price for at least 15 out of 30 consecutive trading days [6]. - The board has the authority to propose a downward adjustment, which requires a two-thirds majority approval from shareholders [6]. Group 4: Recent Board Decision - On April 3, 2025, the board held a meeting and unanimously decided not to adjust the conversion price, citing significant fluctuations in stock prices due to macroeconomic factors [2][8][11]. - The board indicated that if the downward adjustment clause is triggered again within the next three months, they will also not propose an adjustment [8].